We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+36.69%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$295M
AUM Growth
+$57.3M
Cap. Flow
-$1.19M
Cap. Flow %
-0.41%
Top 10 Hldgs %
11.55%
Holding
533
New
131
Increased
95
Reduced
150
Closed
122

Top Buys

Rank Stock Value
1
RBC icon
RBC Bearings
RBC
+$1.93M
2
WING icon
Wingstop
WING
+$1.92M
3
CTRE icon
CareTrust REIT
CTRE
+$1.92M
4
ELV icon
Elevance Health
ELV
+$1.59M
5
HEI icon
HEICO Corp
HEI
+$1.49M

Sector Composition

Rank Sector Weight
1 Technology 22.77%
2 Healthcare 18.27%
3 Industrials 14.69%
4 Consumer Discretionary 12.35%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
126
DELISTED
Blueprint Medicines
BPMC
$843K 0.29%
10,813
-14,950
-58% -$1.01M
AMD icon
127
Advanced Micro Devices
AMD
$901B
$820K 0.28%
15,592
-3,703
-19% -$196K
HCSG icon
128
Healthcare Services Group
HCSG
$1.62B
$820K 0.28%
+33,541
New +$794K
RDFN
129
DELISTED
Redfin
RDFN
$816K 0.28%
+19,481
New +$513K
QDEL icon
130
QuidelOrtho
QDEL
$1.14B
$811K 0.28%
+3,623
New +$568K
UI icon
131
Ubiquiti
UI
$32.5B
$809K 0.27%
4,635
-700
-13% -$117K
HASI icon
132
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$807K 0.27%
28,356
-14,426
-34% -$394K
GLOB icon
133
Globant
GLOB
$1.32B
$800K 0.27%
5,342
+2,535
+90% +$313K
MRSN
134
DELISTED
Mersana Therapeutics
MRSN
$797K 0.27%
1,362
-313
-19% -$107K
ROKU icon
135
Roku
ROKU
$21.2B
$791K 0.27%
6,786
+3,943
+139% +$451K
IWM icon
136
iShares Russell 2000 ETF
IWM
$81.6B
$789K 0.27%
+5,508
New +$723K
KNSA icon
137
Kiniksa Pharmaceuticals
KNSA
$4.8B
$787K 0.27%
+30,870
New +$645K
ATVI
138
DELISTED
Activision Blizzard
ATVI
$772K 0.26%
10,169
+4,057
+66% +$283K
WWE
139
DELISTED
World Wrestling Entertainment
WWE
$769K 0.26%
+17,699
New +$760K
CNST
140
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$768K 0.26%
+25,572
New +$921K
CBPO
141
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$751K 0.26%
+7,347
New +$786K
PXD
142
DELISTED
Pioneer Natural Resource Co.
PXD
$738K 0.25%
7,556
-6,364
-46% -$561K
MTEM
143
DELISTED
Molecular Templates, Inc.
MTEM
$734K 0.25%
+3,549
New +$825K
AL
144
DELISTED
Air Lease Corp
AL
$732K 0.25%
+25,002
New +$667K
CMD
145
DELISTED
Cantel Medical Corporation
CMD
$715K 0.24%
+16,155
New +$603K
MANT
146
DELISTED
Mantech International Corp
MANT
$697K 0.24%
10,175
-2,380
-19% -$175K
ARDX icon
147
Ardelyx
ARDX
$1.25B
$685K 0.23%
99,056
SWCH
148
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$685K 0.23%
38,431
+12,410
+48% +$217K
EVER icon
149
EverQuote
EVER
$880M
$683K 0.23%
11,740
-4,320
-27% -$203K
AEL
150
DELISTED
American Equity Investment Life Holding Company
AEL
$681K 0.23%
+27,559
New +$575K

Similar funds

Algert Global's Q2 2020 Portfolio in Review

As of Q2 2020, Algert Global held 533 positions worth $295M, up 24% from $237M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Algert Global's Q2 2020 filing shows 131 new, 95 increased, 150 reduced and 122 closed positions. Its largest new stake was RBC Bearings: 15,099 shares worth $2.02M. The largest sale was Meta Platforms (Facebook), an estimated $1.98M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Algert Global's largest Q2 2020 buy was RBC Bearings: 15,099 shares worth $2.02M.
  • Algert Global added most to Crown Castle in Q2 2020, an estimated $1.32M increase.
  • Algert Global's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $1.98M.
  • Algert Global fully exited Agree Realty in Q2 2020, selling an estimated $1.47M.
  • Algert Global's ten largest holdings make up 12% of its $295M portfolio in Q2 2020.
  • Algert Global opened 131 new positions and closed 122 in Q2 2020.
  • Algert Global's portfolio value rose 24% quarter-over-quarter to $295M.

Based on Algert Global's 13F filing for Q2 2020, filed 12 Aug 2020.